Detalhe da pesquisa
1.
Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation.
Am J Gastroenterol
; 116(2): 354-361, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33065589
2.
Low-Dose Linaclotide (72 µg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Am J Gastroenterol
; 113(1): 105-114, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29091082
3.
A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects.
J Allergy Clin Immunol
; 122(3): 544-9, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18692886
4.
Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis.
Expert Rev Gastroenterol Hepatol
; 13(4): 397-406, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30791771
5.
Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
Curr Med Res Opin
; 22(6): 1217-26, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16846555
6.
Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma.
Ann Allergy Asthma Immunol
; 99(6): 540-8, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18219836